A traumatic patient brought to the emergency department with loss of massive blood volume and coagulation factors. Which blood product would be prescribed?

1. A

   Cryoprecipitate

2. B

   FFP

3. C

   PRBC

4. D

   Platelets

Appeared in: NORCET 5 mains

Explanation

Listen in Hindi

• The patient has lost both blood volume and coagulation factors due to trauma.
• Fresh Frozen Plasma (FFP) is the blood product that contains all the coagulation factors present in normal plasma.
• Administering FFP directly addresses the coagulopathy (impaired clotting) by replenishing the lost factors.
• FFP also contributes to volume expansion, helping to stabilize the patient's hemodynamic status.
• It is the first-line therapy for correcting multiple coagulation factor deficiencies in the setting of massive hemorrhage.

Why Other Options Were Wrong

• Option A: Cryoprecipitate contains only a concentrated subset of clotting factors (fibrinogen, Factor VIII, vWF, Factor XIII). It does not replace all the factors lost in massive hemorrhage.
• Option C: Packed Red Blood Cells (PRBCs) are used to restore oxygen-carrying capacity by replacing lost red blood cells. They contain minimal plasma and no significant amount of clotting factors.
• Option D: Platelets are cellular components essential for forming the initial plug at a bleeding site. They are not the same as the soluble protein coagulation factors found in plasma.

Related Visual

• Visual 1: Table - A comparative table showing the components and primary indications for PRBCs, FFP, Platelets, and Cryoprecipitate. This helps learners quickly differentiate between the products.
• Visual 2: Flowchart - A diagram illustrating a typical Massive Transfusion Protocol (MTP), showing the sequence and ratio (e.g., 1:1:1) of administering PRBCs, FFP, and platelets in a trauma setting.

Clinical Relevance

• Nursing practice connection: Prioritize focused assessment, early escalation, and real-time monitoring when managing Management of massive hemorrhage and coagulopathy with blood products in acute care settings.
• In trauma care, Massive Transfusion Protocols (MTPs) are critical. Nurses play a key role in activating the MTP, ensuring correct blood product administration, and monitoring the patient's response.
• Key nursing monitoring includes vital signs, signs of ongoing bleeding, and laboratory values like hemoglobin, hematocrit, platelet count, PT/INR, aPTT, and fibrinogen levels.
• Nurses must be vigilant for transfusion reactions (e.g., fever, chills, hives, hypotension, respiratory distress) and circulatory overload (TACO), especially when large volumes are infused rapidly.

How to Approach the Question

• First, analyze the patient's condition described in the stem. The key problems are 'massive blood volume' loss and 'loss of coagulation factors'.
• Next, consider the primary function of each blood product listed in the options.
• Evaluate Option A (Cryoprecipitate): This is a concentrate of specific factors, not a broad replacement.
• Evaluate Option B (FFP): This contains all plasma clotting factors. This directly matches the patient's need for 'coagulation factors'.
• Evaluate Option C (PRBC): This replaces red blood cells for oxygen transport, not clotting factors.
• Evaluate Option D (Platelets): This replaces platelets for primary hemostasis, not plasma clotting factors.

Concept Tested & Keywords

• Concept Tested: Management of massive hemorrhage and coagulopathy with blood products.
• Stem keywords: traumatic patient, emergency department, massive blood volume, coagulation factors
• Lead-in keywords: Which blood product
• Clinical cues: The combination of massive blood loss and loss of coagulation factors points towards a dilutional or traumatic coagulopathy, requiring replacement of clotting factors.

Question ID

QV2-XFGK_HOIer835D_8ke

Copy ID